Earl R Lewis
CIK 1230427 · View on SEC EDGAR ↗
First SEC filing: Feb. 12, 2014 · Latest: Feb. 12, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 25, 2017 | HBIO | P | 7,238 | $2.33 | $16,865 | 467,350 Direct | +1.57% | Acquired | -67.4% (price as of 2026-08-21) |
| May 25, 2017 | HBIO | P | 5,000 | $2.38 | $11,900 | 460,112 Direct | +1.10% | Acquired | -68.1% (price as of 2026-08-21) |
| May 24, 2017 | HBIO | P | 5,000 | $2.37 | $11,850 | 433,012 Direct | +1.17% | Acquired | -68.0% (price as of 2026-08-21) |
| May 23, 2017 | HBIO | P | 5,000 | $2.39 | $11,950 | 428,012 Direct | +1.18% | Acquired | -68.2% (price as of 2026-08-21) |
| Dec. 6, 2016 | HBIO | S | 23,088 | $2.42 | $55,873 | 392,012 Direct | -5.56% | Disposed | -68.6% (price as of 2026-08-21) |
| Dec. 2, 2015 | HBIO | P | 27,221 | $3.28 | $89,285 | 389,800 Direct | +7.51% | Acquired | -76.9% (price as of 2026-08-21) |
| Sept. 16, 2009 | HBIO | P | 5,534 | $3.75 | $20,752 | 70,000 Direct | +8.58% | Acquired | -73.3% (price as of 2026-08-21) |
| Sept. 15, 2009 | HBIO | P | 8,731 | $3.73 | $32,567 | 64,466 Direct | +15.67% | Acquired | -73.2% (price as of 2026-08-21) |
| Sept. 15, 2009 | HBIO | P | 700 | $3.72 | $2,604 | 55,735 Direct | +1.27% | Acquired | -73.1% (price as of 2026-08-21) |
| Sept. 15, 2009 | HBIO | P | 300 | $3.73 | $1,119 | 55,035 Direct | +0.55% | Acquired | -73.2% (price as of 2026-08-21) |
| Sept. 15, 2009 | HBIO | P | 4,466 | $3.69 | $16,480 | 54,735 Direct | +8.88% | Acquired | -72.9% (price as of 2026-08-21) |
| Sept. 15, 2009 | HBIO | P | 269 | $3.70 | $995 | 50,269 Direct | +0.54% | Acquired | -72.9% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 32 | $2.00 | $64 | 50,000 Direct | +0.06% | Acquired | -49.9% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 2,772 | $2.05 | $5,683 | 49,968 Direct | +5.87% | Acquired | -51.2% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 2,100 | $2.05 | $4,305 | 47,196 Direct | +4.66% | Acquired | -51.2% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 3,862 | $2.10 | $8,110 | 45,096 Direct | +9.37% | Acquired | -52.3% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 2,900 | $2.05 | $5,945 | 41,234 Direct | +7.57% | Acquired | -51.2% (price as of 2026-08-21) |
| Dec. 2, 2008 | HBIO | P | 3,334 | $2.02 | $6,735 | 38,334 Direct | +9.53% | Acquired | -50.4% (price as of 2026-08-21) |
| Dec. 1, 2008 | HBIO | P | 10,000 | $2.03 | $20,300 | 35,000 Direct | +40.00% | Acquired | -50.7% (price as of 2026-08-21) |
| Dec. 11, 2007 | HBIO | P | 15,000 | $4.40 | $66,000 | 25,000 Direct | +150.00% | Acquired | -77.2% (price as of 2026-08-21) |
| Dec. 11, 2007 | HBIO | P | 10,000 | $4.25 | $42,500 | 10,000 Direct | — | Acquired | -76.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 9, 2015 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (3,301) | $3.71 | May 24, 2017 | 3,301 | Disposed |
| June 9, 2015 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (7,070) | $2.56 | June 1, 2022 | 7,070 | Disposed |
| March 4, 2015 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (47,414) | $4.04 | June 2, 2021 | 47,414 | Disposed |
| Nov. 6, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (14,143) | $2.56 | June 1, 2022 | 14,143 | Disposed |
| Nov. 6, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (3,294) | $3.01 | May 25, 2016 | 3,294 | Disposed |
| Nov. 6, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (3,293) | $3.41 | May 22, 2018 | 3,293 | Disposed |
| Nov. 6, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (15,016) | $3.64 | May 31, 2023 | 15,016 | Disposed |
| Aug. 5, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (45,090) | $2.59 | June 4, 2020 | 45,090 | Disposed |
| May 5, 2014 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (3,303) | $3.32 | June 4, 2014 | 3,303 | Disposed |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (3,616) | $3.64 | May 31, 2023 | 3,616 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (5,113) | $2.56 | June 1, 2022 | 5,113 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (11,414) | $4.04 | June 2, 2021 | 11,414 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (10,890) | $2.59 | June 4, 2020 | 10,890 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (793) | $3.41 | May 22, 2018 | 793 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (801) | $3.71 | May 24, 2017 | 801 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (803) | $3.32 | June 4, 2014 | 803 | Acquired |
| Nov. 1, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (794) | $3.01 | May 25, 2016 | 794 | Acquired |
| May 31, 2013 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (11,400) | $5.08 | May 31, 2023 | 11,400 | Acquired |
| Feb. 19, 2013 | HBIO | Stock option (right to buy) | Common stock, par value $0.01 per share (27,500) | $3.72 | May 30, 2013 | 27,500 | Disposed |
| June 1, 2012 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (16,100) | $3.57 | June 1, 2022 | 16,100 | Acquired |
| June 2, 2011 | HBIO | Non- Qualified Stock Option (Right to buy) | Common Stock, par value $0.01 per share (36,000) | $5.64 | June 2, 2021 | 36,000 | Acquired |
| June 4, 2010 | HBIO | Non-Qualified Stock Option (Right to Buy) | Common Stock, par value $0.01 per share (34,200) | $3.61 | June 4, 2020 | 34,200 | Acquired |
| May 21, 2009 | HBIO | Non-qualified Stock Option (right to Buy) | Common Stock, par value $0.01 per share (18,000) | $3.18 | May 21, 2019 | 18,000 | Acquired |
| May 21, 2009 | HBIO | Non-qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (18,000) | $3.18 | May 21, 2019 | 18,000 | Acquired |
| May 22, 2008 | HBIO | Non-qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (2,500) | $4.76 | May 22, 2018 | 2,500 | Disposed |
| May 24, 2007 | HBIO | Non-qualified Stock Option (right to buy) | Common stock, par value $0.01 per share (2,500) | $5.17 | May 24, 2017 | 2,500 | Acquired |
| May 25, 2006 | HBIO | Non-qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (2,500) | $4.20 | May 25, 2016 | 2,500 | Acquired |
| May 26, 2005 | HBIO | Non-qualified Stock Option (right to buy) | Common Stock (10,000) | $3.00 | May 26, 2015 | 10,000 | Acquired |
| June 4, 2004 | HBIO | Non-Qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (2,500) | $4.63 | June 4, 2014 | 2,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).